Anti-β2-glycoprotein I antibodies - When and how should they be measured?

Thrombosis Research

Volumn 114, Issue 5-6 SPEC. ISS., 2004, Pages 527-531

  Reber, Guido ^a,b   De Moerloose, Philippe ^a  

^a Univ Hosp   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Assays; Pregnancy loss; Thromboembolic disease

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID ANTIBODY; PROTEIN ANTIBODY; PROTHROMBIN ANTIBODY; GLYCOPROTEIN;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CEREBROVASCULAR DISEASE; DISEASE SEVERITY; ECLAMPSIA AND PREECLAMPSIA; HEADACHE; HUMAN; MORBIDITY; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SCREENING TEST; STANDARDIZATION; SYPHILIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; UNITED STATES; VEIN THROMBOSIS; BLOOD; CHEMISTRY; CLASSIFICATION; CLINICAL CHEMISTRY; FEMALE; IMMUNOLOGY; MALE; RECURRENT ABORTION; REPRODUCIBILITY; THROMBOSIS; TIME;

ABORTION, HABITUAL; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CHEMISTRY, CLINICAL; FEMALE; GLYCOPROTEINS; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; PREGNANCY; REPRODUCIBILITY OF RESULTS; THROMBOSIS; TIME FACTORS;

EID: 7044236943     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.06.034     Document Type: Article

References (27)

1. H.P. McNeil, R.J. Simpson, C.N. Chesterman, and S.A. Krilis Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H) Proc. Natl. Acad. Sci. U. S. A. 87 1990 4120 4124
2. M. Galli, P. Comfurius, C. Maasen, H.C. Hemker, M.H. de Baets, and P.J.C. van Breda-Vriesman Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor Lancet 335 1990 1544 1547
3. E. Matsuura, Y. Igarashi, K. Fujimoto, K. Ichikawa, and T. Koike Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease Lancet 336 1990 177
4. J.P. Viard, Z. Amoura, and J.F. Bach Association of anti-beta2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus Am. J. Med. 93 1992 181 186
5. W.A. Wilson, A.E. Gharavi, T. Koike, D. Lockshin, D.W. Branch, and J.-C. Piette International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome Arthritis Rheum. 42 1999 1309 1311
6. V. Pengo. Communication, 48th Annual SSC meeting, Boston, MA, USA, July 18, 2002. See annual SSC reports at the ISTH website: http://www.med.unc.edu/ isth.
7. M. Galli, D. Luciani, G. Bertolini, and T. Barbui Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood 101 2003 1827 1832
8. M. Galli, B. Luciani, G. Bertolini, and T. Barbui Anti-β2- glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome Blood 102 2003 2717 2723
9. K. Hsieh, P. Knöbl, C. Rintelen, P.A. Kyrle, P. Quehenberger, and C. Bialonczyk Is the determination of anti-beta 2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome? Br. J. Haematol. 123 2003 490 495
10. V. Caso, L. Parnetti, P. Panarelli, M.P. Magni, V. Gallai, and E. Albi Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients J. Neurol. 250 2003 593 597
11. A. Amoroso, A.P. Mitterhofer, F. Del Porto, P. Garzia, G.M. Ferri, and S. Galluzzo Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus Hum. Immunol. 64 2003 265 273
12. F. Ebeling, T. Pettersson, L. Muukkonen, E. Vahtera, and V. Rasi Beta-2-glycoprotein I antibodies in patients with thrombosis Scand. J. Clin. Lab. 63 2003 11 18
13. L.R. Lopez, K.J. Dier, D. Lopez, J.T. Merrill, and C.A. Fink Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome Am. J. Clin. Pathol. 121 2004 142 149
14. I. Marai, B. Gilburd, M. Blank, and Y. Shoenfeld Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome Hum. Antib. 12 2003 57 62
15. B. Myers, and J. Gould The place of beta 2 glycoprotein 1 in the assessment of antiphospholipid syndrome Blood Coagul. Fibrinolysis 14 2003 1 2
16. R.R. Forastiero, M.E. Martinuzzo, G.S. Cerrato, L.C. Kordich, and L.O. Carreras Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies Thromb. Haemost. 78 1997 1008 1014
17. J.C. Gris, I. Quere, M. Sanmarco, B. Boutiere, E. Mercier, and J. Amiral Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nimes Obstetricians and Haematologists Study-NOHA Thromb. Haemost. 84 2000 228 236
18. R.M. Lee, W. Emlen, J.R. Scott, D.W. Branch, and R.M. Silver Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome Am. J. Obstet. Gynecol. 181 1999 642 648
19. D. Faden, A. Tincani, P. Tanzi, L. Spatola, A. Lojacono, and M. Tarantini Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia Eur. J. Obstet. Gynecol. Reprod. Biol. 73 1997 37 42
20. R.M. Lee, M.A. Brown, D.W. Branch, K. Ward, and R.M. Silver Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia Obstet. Gynecol. 102 2003 294 300
21. D. Detkova, A. Gil-Aguado, P. Lavilla, M.V. Cuesta, G. Fontan, and D. Pascual-Salcedo Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome Lupus 8 1999 430 438
22. E.Y. Lee, C.K. Lee, T.H. Lee, S.M. Chung, S.H. Kim, and Y.S. Cho Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis? Thromb. Res. 111 2003 29 32
23. G. Reber, J. Arvieux, E. Comby, D. Degenne, P. de Moerloose, and M. Sanmarco Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies Thromb. Haemost. 73 1995 444 452
24. A. Tincani, F. Allegri, M. Sanmarco, M. Cinquini, M. Taglietti, and G. Balestrieri Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations. A cooperative project of the European antiphospholipid forum Thromb. Haemost. 86 2001 575 583
25. G. Reber, I. Schousboe, A. Tincani, M. Sanmarco, T. Kveder, and P. Moerloose Inter-laboratory variability of anti-β2-glycoprotein I measurement. A collaborative study in the frame of the European forum on antiphospholipid antibodies standardization group Thromb. Haemost. 88 2002 66 73
26. 2-glycoprotein I antibodies, Standardisation Group of the European Forum on Antiphospholipid Antibodies. J. Thromb. Haemost., in press.
27. K. Ichikawa, A. Tsutsumi, T. Atsumi, E. Matsuura, S. Kobayashi, and G.R. Hughes A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies Arthritis Rheum. 42 1999 2461 2470